Changing periods
Cycles may become shorter, longer, heavier or less predictable during perimenopause. Bleeding after 12 months without a period is not an expected menopause symptom and needs assessment.
Practical support for hot flushes, sleep, mood, vaginal and urinary symptoms, changing bleeding, sexual wellbeing and future bone and heart health.
Symptoms can begin before periods stop and vary over time. Assessment considers other possible causes rather than assuming every new symptom is menopause.
Cycles may become shorter, longer, heavier or less predictable during perimenopause. Bleeding after 12 months without a period is not an expected menopause symptom and needs assessment.
Vasomotor symptoms can disturb sleep, work and concentration. Severity—not whether someone “should cope”—guides whether treatment is useful.
Sleep disruption, anxiety, low mood and difficulty concentrating can occur, but thyroid disease, depression, medicines and other causes may also need consideration.
Dryness, burning, pain during intercourse, urinary urgency or repeated infections can reflect genitourinary syndrome of menopause and often persist without treatment.
Bone loss accelerates around menopause. Early menopause, fractures, steroid use, low body weight and family history can justify earlier risk assessment.
Comfort, desire, relationships and body changes can be discussed directly. Treatment may involve local symptom care, counselling and review of medicines or health conditions.
Choice depends on symptoms, uterus status, age, time since menopause, medical history and preference. Treatment is reviewed rather than continued automatically.
Regular resistance and weight-bearing activity, adequate nutrition, tobacco avoidance and sleep support improve general health but do not need to be presented as a cure for every symptom.
Systemic oestrogen—with progestogen when a uterus is present—can be highly effective for hot flushes and related symptoms in appropriately selected patients. Personal risks, route, dose and review matter.
Selected prescription medicines and behavioural approaches can reduce hot flushes or improve sleep when hormone therapy is unsuitable or not preferred.
Vaginal moisturisers and lubricants help some people. Low-dose vaginal oestrogen or other prescription options may be considered for persistent vaginal and urinary symptoms.
Bleeding, spotting or blood-stained discharge after 12 months without periods should not be attributed to “hormonal changes” without review. Evaluation may include examination, ultrasound and endometrial assessment according to findings and risk.
A menopause visit can review blood pressure, diabetes and cholesterol risk, cervical and breast screening, bone-health factors, contraception, sexual health and emotional wellbeing.
Explore preventive healthReview fracture history, early menopause, medicines and whether bone-density testing is indicated.
Address blood pressure, glucose, cholesterol, tobacco, activity and pregnancy history directly.
Continue cervical and breast screening according to age, previous results and individual risk.
Reassess symptom benefit, bleeding, side effects and evolving health rather than using a fixed plan forever.
Perimenopause is the transition while cycles and symptoms change. Menopause is confirmed retrospectively after 12 consecutive months without a period when there is no other cause.
No treatment suits everyone. Benefits are often favourable for healthy, symptomatic people near the menopause transition, but personal history of clotting, stroke, breast or endometrial cancer, liver disease and unexplained bleeding changes the discussion.
Pregnancy becomes less likely but remains possible during perimenopause. Continue contraception until menopause is reliably established according to age, method and clinical guidance.
Yes. Any bleeding after menopause should be assessed, even if light or occurring only once. Most causes are not cancer, but cancer or precancer must be excluded.
Hormone therapy is not prescribed solely to prevent heart disease. Blood pressure, glucose, cholesterol, tobacco, activity and individual cardiovascular risk should be managed directly.